MARKETS
Earnings

Microbix Biosystems Q3 EPS $(0.01) Beats $(0.68) Estimate, Sales $4.059M Miss $5.200M Estimate

Aug 13, 2026 · 07:51 AM ET· updated 1h ago

Microbix Biosystems (TSX:MBX) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.68) by 98.53 percent. This is a 0 percent increase over losses of $(0.01) per share from the

Share
Why It Matters

Microbix lost less money than experts thought it would, which sounds good, but the company made much less money from sales than people expected. When a company earns less than hoped, it usually means business isn't growing as fast as people wanted.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.